Abivax SA Sponsored ADR (ABVX)
(Delayed Data from NSDQ)
$13.73 USD
-0.13 (-0.94%)
Updated May 28, 2024 03:59 PM ET
After-Market: $13.70 -0.03 (-0.22%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
ABVX 13.73 -0.13(-0.94%)
Will ABVX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ABVX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ABVX
Abivax initiated with bullish view at BTIG, here's why
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Abivax SA Sponsored ADR (ABVX)
Abivax SA Announces Upcoming General Meeting
Apple upgraded, Tesla downgraded: Wall Street's top analyst calls
Abivax initiated with a Buy at Guggenheim on obefazimod's potential